Detrusitol SR Capsule 2 Milligrams (Tolterodine L-Tartrate)

Adult dose

Adults: Administer 4 mg of tolterodine L-tartrate orally once daily. Patients with renal impairment, patients with hepatic impairment, or patients taking ketoconazole or another potent CYP3A4 inhibitor: Administer 2 mg of this medicine once daily. If adverse reactions occur, the dose may be reduced from 4 mg to 2 mg once daily. This medicine may be taken with or without food. Swallow the dosage form whole; do not crush or split it.

This medication should not be used in patients with urinary retention or slow gastrointestinal motility as symptoms may worsen. It should also be avoided in patients with uncontrolled glaucoma, myasthenia gravis, or severe ulcerative colitis. When using this medication, caution should be exercised in patients with a risk of urinary retention, gastrointestinal obstruction, or kidney and liver dysfunction. Particular attention is needed when taken with certain antibiotics, antifungals, or immunosuppressants, as drug interactions may occur. This medication can cause side effects such as dry mouth, dyspepsia, constipation, and decreased tears, and rarely allergic reactions or neurological symptoms may occur. Before administration, cardiac conditions should be checked in patients with arrhythmias or a risk of QT prolongation, and concomitant use with strong CYP3A4 inhibitors should be avoided. Caution is required when driving or operating machinery, and an assessment of bladder function or urinary tract issues is necessary before taking this medication. It is safer for women who are pregnant or breastfeeding to avoid this medication, and appropriate contraception is recommended for women of childbearing age. The safety and efficacy in children have not been sufficiently established, so it should be used with caution in pediatric patients. In case of overdose, immediate medical attention should be sought, and treatment may include administering an antidote or symptomatic care as necessary. This medication should be stored out of the reach of children, and it is safer not to transfer it into another container.

• Dry mouth
• dyspepsia
• decreased tear production
• bronchitis
• allergic reaction
• confusion
• drowsiness
• dizziness
• headache
• hyperesthesia

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. Additionally, it is best to keep the medication at room temperature below 25 degrees Celsius.

Appearance

A capsule with a light white granule in a blue-green upper and lower part.

Package unit

30 capsules/bottle